Post by
hoffbag on Apr 22, 2021 11:11am
results pretty good
Tough year to be moving operations (across country). Appears that Covid socked it to them in the 2nd half results. However, with the dust settling on operations will be watching for the uptrend now. I know most are looking at the business development side but I would like to see them continue to grow the foundation they have as cash flow appears good and it supports the bells and whistles.
Regarding development seems like not too much action or clarity. Hard to get a sense of progress. Will knock them on that.
It is nice to see a small cap "kind of biotech" that is able to pay its way and has a business. Its a competitive world and if they hope to reach the next level they have to get way more aggressive.
Comment by
Ciao on Apr 22, 2021 12:30pm
Keep in mint they spent just under $2M in R&D for a company that generated $15M in revenue and they still managed to have a net profit of $1.8M and cash and cash equivalents went up $3.5M to $5.3M.
Comment by
Stinzo on Apr 22, 2021 12:32pm
Ciao and other shareholders, I purchased 50k shares today. We should be in a good position by end of year.
Comment by
Ciao on Apr 22, 2021 12:38pm
Stinzo, Good luck to you on those shares which is good luck to us all :-) I know you sold some late last year.
Comment by
Stocker46 on Apr 22, 2021 1:51pm
Stinzo "purchased 50k shares today" .. I sold close to the same & was surprised to get the price I did. If there was no reason for the price to go up before the 4th Q release, there's certainly no reason for it to go up now. Just looking at my investment account & there are 10 times as many sellers as buyers .. the ask is 73 cents. (current price 75 cents).